5-Fluoroisatin

5-Fluoroisatin

SCHEMBL734148

CCOC(=O)CC1(O)C(=O)Nc2ccc(F)cc21.O=C1Nc2ccc(F)cc2C1=O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.41
MAOA P21397 3/20 0.41
IDO1 P14902 2/20 0.40
AURKA O14965 1/20 0.40
MAPT P10636 1/20 0.39
CASP3 P42574 1/20 0.38
CBX7 O95931 1/20 0.38
CDYL2 Q8N8U2 1/20 0.38
CDYL Q9Y232 1/20 0.38
CDY1; CDY1B Q9Y6F8 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
BRD4 O60885 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
GSK3B P49841 1/20 0.36
USP2 O75604 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL699106 0.90 IDO1 (0.48) IDO1MAPTCBX7CDYL2CDYL
SCHEMBL27780994 0.76 USP2 (0.55) IDO1MAPTCBX7CDYL2CDYL
SCHEMBL12440856 0.74 IDO1 (0.54) IDO1MAPTCBX7CDYL2CDYL
SCHEMBL700627 0.74 IDO1 (0.69) IDO1MAPTCBX7CDYL2CDYL
SCHEMBL735234 0.72 IDO1 (0.59) IDO1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL27780980 0.72 ALDH1A1 (0.47) IDO1MAPTKMT2AALDH1A1LMNA
5-Fluoroisatin SCHEMBL183575 0.71 MAOB (0.61) MAOBMAOACASP3ALDH1A1
5-Fluoroisatin SCHEMBL8708925 0.71 MAOB (0.51) MAOBMAOACASP3KMT2AALDH1A1
SCHEMBL734639 0.70 IDO1 (0.47) IDO1MAPTCBX7CDYL2CDYL
SCHEMBL12273071 0.70 TGM2 (0.56) MAOBMAOAIDO1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 MAOB 686/4885MAOA 367/4885IDO1 2394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.